jaF0
Moderator
- Joined
- Dec 31, 2009
- Posts
- 39,168
Regeneron Expects Zero Covid Antibody Sales For The First Quarter Of 2022
Forbes|2 hours ago
The company's antibody therapy has been determined to be ineffective against the omicron variant that now dominates Covid-19 cases worldwide.
https://www.forbes.com/sites/aayush...antibody-sales-for-the-first-quarter-of-2022/
Forbes|2 hours ago
The company's antibody therapy has been determined to be ineffective against the omicron variant that now dominates Covid-19 cases worldwide.
https://www.forbes.com/sites/aayush...antibody-sales-for-the-first-quarter-of-2022/